Characteristics | Training set (n = 1,200) | Validation set (n = 1,118) | P value |
---|---|---|---|
Demographic characteristics | |||
Male (n (%)) | 554 (46.2) | 507 (45.3) | 0.693 |
Age (years, M (IQR)) | 43 (31–51) | 43 (31–51) | 0.396 |
BMI (kg/m2, M (IQR)) | 22.31(20.38–24.45) | 22.43 (20.58–24.56) | 0.322 |
WC (cm, M (IQR)) | 80 (74–87) | 80 (74–86) | 0.822 |
HC (cm, M (IQR)) | 94 (90–98) | 94 (91–99) | 0.089 |
SBP (mmHg, M (IQR)) | 118 (108–126) | 118 (108–125) | 0.439 |
DBP (mmHg, M (IQR)) | 78 (70–84) | 78 (70–84) | 0.626 |
Smoker (n (%)) | 202 (16.8) | 161 (14.4) | 0.157 |
Tea drinkers (n (%)) | 634 (52.8) | 570 (51.0) | 0.625 |
Hypertension (n (%)) | 217 (18.1) | 190 (17.0) | 0.491 |
Diabetes (n (%)) | 59 (4.9) | 49 (4.4) | 0.542 |
NAFLD (n (%)) | 272 (22.7) | 257 (23.0) | 0.854 |
Clinical characteristics | |||
GGT (U/L, M (IQR)) | 20 (15–29) | 20 (15–30) | 0.675 |
ALT (U/L, M (IQR)) | 18 (13–26) | 18 (13–25) | 0.990 |
AST (U/L, M (IQR)) | 20 (18–24) | 21 (18–24) | 0.734 |
FPG (mmol/L, M (IQR)) | 5.13 (4.87–5.43) | 5.16 (4.92–5.45) | 0.227 |
TC (mmol/L, M (IQR)) | 4.98 (4.53–5.51) | 4.97 (4.56–5.46) | 0.696 |
TG (mmol/L, M (IQR)) | 1.15 (0.88–1.59) | 1.13 (0.88–1.59) | 0.431 |
LDL-C (mmol/L, M (IQR)) | 3.11 (2.66–3.57) | 3.11 (2.69–3.52) | 0.991 |
HDL-C (mmol/L, M (IQR)) | 1.37 (1.18–1.47) | 1.36 (1.17–1.46) | 0.278 |
AIP (M (IQR)) | -0.060 (-0.217–0.127) | -0.069 (-0.217–0.115) | 0.655 |